Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.51 |
| ▸ | MGLL | Q99685 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19056796 | 0.94 | DHFR (0.47) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL22357201 | 0.89 | ALDH1A1 (0.47) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL21801767 | 0.86 | DHFR (0.59) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL121520 | 0.86 | DHFR (0.59) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL29374975 | 0.86 | DHFR (0.59) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL157854 | 0.86 | DHFR (0.48) | DHFRMGLLMAPK1L3MBTL1ALDH1A1 | |
| SCHEMBL11143008 | 0.86 | DHFR (0.54) | DHFRMGLLTDP1MAPK1L3MBTL1 | |
| SCHEMBL9153659 | 0.83 | DHFR (0.60) | DHFRMGLLMAPK1L3MBTL1ALDH1A1 | |
| SCHEMBL10349642 | 0.83 | HRH3 (0.50) | MGLLALDH1A1MAPT | |
| SCHEMBL1715848 | 0.83 | DHFR (0.53) | DHFRMGLLTDP1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023238920-A1 | COMPOSITION FOR FORMING RESIST UNDERLAYER FILM TO REDUCE ENVIRONMENTAL IMPACT | 日産化学株式会社 | 2023-12-14 | — | — | WO | disclosed |
| WO-2023182408-A1 | COMPOSITION FOR FORMING RESIST-LOWER-LAYER FILM INCLUDING FLUORENE SKELETON | 日産化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| WO-2023181960-A1 | COMPOSITION FOR FORMING PROTECTIVE FILM | 日産化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| WO-2023149327-A1 | PROTECTIVE FILM FORMING COMPOSITION | 日産化学株式会社 | 2023-08-10 | — | — | WO | disclosed |
| WO-2023058368-A1 | METHOD FOR PRODUCING GLASS SUBSTRATE, PRETREATMENT METHOD FOR GLASS SUBSTRATE, AND METHOD FOR PRODUCING MULTILAYER BODY COMPRISING GLASS SUBSTRATE | 日産化学株式会社 | 2023-04-13 | — | — | WO | disclosed |
| US-20220404706-A1 | CHEMICAL-RESISTANT POLYVALENT CARBOXYLIC ACID-CONTAINING PROTECTIVE FILM | NISSAN CHEMICAL CORPORATION (JP) | 2022-12-22 | — | — | US | disclosed |
| US-20220153920-A1 | METHOD FOR PRODUCING POLYMER | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| US-20220145119-A1 | CHEMICAL SOLUTION-RESISTANT PROTECTIVE FILM FORMING COMPOSITION CONTAINING POLYMERIZATION PRODUCT HAVING DIOL STRUCTURE AT TERMINAL THEREOF | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20210403635-A1 | CHEMICAL-RESISTANT PROTECTIVE FILM-FORMING COMPOSITION CONTAINING POLYMERIZATION PRODUCT OF ARYLENE COMPOUND HAVING GLYCIDYL GROUP | NISSAN CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | disclosed |
| WO-2021085397-A1 | CHEMICAL-RESISTANT POLYCARBOXYLIC ACID-CONTAINING PROTECTIVE FILM | 日産化学株式会社 | 2021-05-06 | — | — | WO | disclosed |
| WO-2020166580-A1 | METHOD FOR PRODUCING POLYMER | 日産化学株式会社 | 2020-08-20 | — | — | WO | disclosed |
| EP-3187515-B1 | POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | TOKUYAMA DENTAL CORP (JP) | 2020-03-18 | — | — | EP | disclosed |
| US-20170253555-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | TOKUYAMA DENTAL CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
| EP-3187515-A1 | POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | Tokuyama Dental Corporation (JP) | 2017-07-05 | — | — | EP | disclosed |
| EP-1942179-B1 | CHIP PROVIDED WITH FILM HAVING HOLE PATTERN WITH THE USE OF THERMORESPONSIVE POLYMER AND METHOD OF PRODUCING THE SAME | TOYAMA PREFECTURE (JP) | 2017-05-10 | — | — | EP | disclosed |
| US-8664003-B2 | Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same | TOYAMA PREFECTURE (JP) | 2014-03-04 | — | — | US | disclosed |
| US-20120301942-A1 | CHIP PROVIDED WITH FILM HAVING HOLE PATTERN WITH THE USE OF THERMORESPONSIVE POLYMER AND METHOD OF PRODUCING THE SAME | TOYAMA PREFECTURE (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20090130384-A1 | Chip Provided with film Having Hole Pattern with the Use of Thermoresponsive Polymer and Method of Producing the Same | TOYAMA PREFECTURE (JP) | 2009-05-21 | — | — | US | disclosed |
| EP-1942179-A1 | CHIP PROVIDED WITH FILM HAVING HOLE PATTERN WITH THE USE OF THERMORESPONSIVE POLYMER AND METHOD OF PRODUCING THE SAME | Toyama Prefecture (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253555-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | H1-0, VMP1, CHRM1 | DHFR 3104/4885MGLL 3630/4885TDP1 1370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.